Hōʻike VLDL

Kū ʻo VLDL i lipoprotein haʻahaʻa haʻahaʻa haʻahaʻa. Hana ʻia nā lipoproteins i ka kolesterol, triglycerides, a me nā protein. Holo lākou i ka cholesterol, triglycerides, a me nā lipids (momona) a puni ke kino.

ʻO VLDL kekahi o nā ʻano nui ʻekolu o nā lipoproteins. Loaʻa i ka VLDL ka nui o nā triglycerides. ʻO VLDL kekahi ʻano o "cholesterol hewa" no ka mea kōkua ia i ke kūkulu ʻana o ka cholesterol ma nā paia o nā aʻa.

Hoʻohana ʻia kahi hōʻike lab e ana i ka nui o VLDL i kou koko.

Pono kahi laʻana koko. ʻO ka hapanui o ka manawa e huki ʻia ke koko mai kahi aa i waiho ʻia ma loko o ka kuʻe lima a i ʻole ka hope o ka lima.

Hiki paha iā ʻoe ke ʻeha iki a i ʻole ke kuʻi ke hoʻokomo ʻia o ka nila. Hiki paha iā ʻoe ke hāwele i kahi kani ma ka pūnaewele ma hope o ka huki ʻia ʻana o ke koko.

Loaʻa paha iā ʻoe kēia hōʻike e kōkua ai i ka loiloi i kāu makaʻu no ka maʻi puʻuwai. Hoʻohui ʻia nā pae hoʻonui o VLDL i ka atherosclerosis. Hiki i kēia ʻano ke alakaʻi i nā maʻi puʻuwau coronary.

Hoʻokomo ʻia kēia hoʻokolohua i loko o kahi ʻike pilikia o ka coronary.

ʻO ka pae kolesterol VLDL maʻamau ma waena o 2 a me 30 mg / dL.

Hiki ke loli iki nā pae waiwai maʻamau i waena o nā hale hana ʻokoʻa. E kamaʻilio me kāu kauka e pili ana i ke ʻano o kāu mau hopena hōʻike kikoʻī.

Hōʻike nā hiʻohiʻona ma luna i nā ana maʻamau no nā hopena no kēia mau hoʻāʻo. Hoʻohana kekahi mau keʻena hoʻokolohua i nā ana like ʻole a i ʻole hoʻokolohua i nā hoʻohālikelike like ʻole.

Hiki ke hoʻopili ʻia kahi pae kolesterol VLDL kiʻekiʻe me ka nui o ka makaʻu no ka maʻi puʻuwai a me ka hahau. Eia nō naʻe, ʻaʻole makemake nui ʻia ka pae kolesterol VLDL ke hana ʻia ka lapaʻau no ke kiʻekiʻe o ka cholesterol. Akā, ʻo ka LDL kolamu pae pinepine ka pahuhopu nui o ka therapy.

ʻOkoʻa nā aʻa a me nā aʻa i ka nui mai kekahi kanaka a i kekahi ʻē aʻe a mai kekahi ʻaoʻao o ke kino i kekahi. ʻOi aku ka paʻakikī o ka loaʻa ʻana o kahi laʻana koko mai kekahi poʻe ma mua o nā poʻe ʻē aʻe.

ʻO nā makaʻi e pili ana i ke kau ʻana o ke koko he liʻiliʻi, akā hiki ke hoʻopili ʻia:

• Kahe nui ke koko
• Pāleʻale a ʻoluʻolu paha
• Hematoma (hōʻiliʻili koko ma lalo o ka ʻili)
• Maʻiʻaʻai (i iki kamepiula i kēlā me kēia manawa ka ʻili i haki)

ʻAʻohe ala pololei o ke ana ʻana iā VLDL. Kuhi ka hapa nui o nā labs i kāu VLDL ma muli o kāu pae triglycerides. Ma kahi o ka hapalima o kāu pae triglycerides. ʻAʻole pololei ke koho ʻana inā ʻoi aku ka kiʻekiʻe o kāu pae triglycerides ma luna o 400 mg / dL.

Hōʻike lipoprotein haʻahaʻa haʻahaʻa haʻahaʻa

• Hōʻaʻo koko

ʻO Chen X, Zhou L, Hussain MM. Lipids a me ka dislipoproteinemia. I: McPherson RA, Pincus MR, hua. ʻO kā Henry's Clinical Diagnosis a me Management e nā Laboratory Methods. 23rd Ed. St Louis, MO: Elsevier; 2017: chap 17.

Grundy SM, Pōhaku NJ, Bailey AL, et al. ʻO 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA Alakaʻi e pili ana i ka mālama ʻana i ke kōkōkō koko: kahi hōʻike o ka American College of Cardiology / American Heart Association Task Force on Clinical Practice Guide. . ʻO J Am Coll Cardiol. 2019; 73 (24): e285-e350. PMID: 30423393 www.ncbi.nlm.nih.gov/pubmed/30423393.

Robinson JG. Nā maʻi o ka lipid metabolism. I: Goldman L, Schafer AI, eds. ʻO ka lāʻau lapaʻau Goldman-Cecil. 26th ed. Piladelapia, PA: Elsevier; 2020: chap 195.